Differential Effects of Oral Boluses of Vitamin D2 vs Vitamin D3 on Vitamin D Metabolism: A Randomized Controlled Trial.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
01 12 2019
Historique:
received: 26 01 2019
accepted: 07 06 2019
pubmed: 15 6 2019
medline: 5 6 2020
entrez: 15 6 2019
Statut: ppublish

Résumé

Vitamin D2 and vitamin D3 have been hypothesized to exert differential effects on vitamin D metabolism. To compare the influence of administering vitamin D2 vs vitamin D3 on metabolism of vitamin D3. We measured baseline and 4-month serum concentrations of vitamin D3, 25-hydroxyvitamin D3 [25(OH)D3], 25-hydroxyvitamin D2, 24R,25-dihydroxyvitamin D3 [24R,25(OH)2D3], 1α,25-dihydroxyvitamin D3 [1α,25(OH)2D3], and 4β,25-dihydroxyvitamin D3 [4β,25(OH)2D3] in 52 adults randomized to receive a total of four oral bolus doses of 2.5 mg vitamin D2 (n = 28) or vitamin D3 (n = 24) over four months. Metabolite-to-parent compound ratios were calculated to estimate hydroxylase activity. Pairwise before vs after comparisons were made to evaluate effects of vitamin D2 and vitamin D3 on metabolism of vitamin D. Mean postsupplementation metabolite-to-parent ratios were then compared between groups. Vitamin D2 was less effective than vitamin D3 in elevating total serum 25(OH)D concentration. Vitamin D2 suppressed mean four-month serum concentrations of 25(OH)D3, 24R,25(OH)2D3, 1α,25(OH)2D3, and 4β,25(OH)2D3 and mean ratios of 25(OH)D3 to D3 and 1α,25(OH)2D3 to 25(OH)D3, while increasing the mean ratio of 24R,25(OH)2D3 to 25(OH)D3. Vitamin D3 increased mean four-month serum concentrations of 25(OH)D3, 24R,25(OH)2D3, 1α,25(OH)2D3, and 4β,25(OH)2D3 and the mean ratio of 24R,25(OH)2D3 to 25(OH)D3. Participants receiving vitamin D2 had lower mean postsupplementation ratios of 25(OH)D3 to vitamin D3 and 1α,25(OH)2D3 to 25(OH)D3 than those receiving vitamin D3. Mean postsupplementation ratios of 24R,25(OH)2D3 to 25(OH)D3 and 4β,25(OH)2D3 to 25(OH)D3 did not differ between groups. Bolus-dose vitamin D2 is less effective than bolus-dose vitamin D3 in elevating total serum 25(OH)D concentration. Administration of vitamin D2 reduces 25-hydroxylation of vitamin D3 and 1-α hydroxylation of 25(OH)D3, while increasing 24R-hydroxylation of 25(OH)D3.

Identifiants

pubmed: 31199458
pii: 5518338
doi: 10.1210/jc.2019-00207
pmc: PMC6797055
doi:

Substances chimiques

Ergocalciferols 0
Vitamins 0
Cholecalciferol 1C6V77QF41
25-Hydroxyvitamin D 2 21343-40-8
24,25-Dihydroxyvitamin D 3 40013-87-4
Calcifediol P6YZ13C99Q

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5831-5839

Subventions

Organisme : Medical Research Council
ID : MC_UP_A100_1003
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12015/4
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12015/5
Pays : United Kingdom
Organisme : NIGMS NIH HHS
ID : R01 GM063666
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Endocrine Society.

Références

J Clin Endocrinol Metab. 2011 Apr;96(4):981-8
pubmed: 21289249
Endocrinology. 2014 Jun;155(6):2052-63
pubmed: 24641623
Am J Clin Nutr. 2010 Jun;91(6):1621-6
pubmed: 20427729
Am J Clin Nutr. 2008 Jun;87(6):1738-42
pubmed: 18541563
Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1498-1506
pubmed: 28768705
J Clin Endocrinol Metab. 2004 Nov;89(11):5387-91
pubmed: 15531486
BMC Endocr Disord. 2019 Jan 18;19(1):8
pubmed: 30658603
J Clin Endocrinol Metab. 2008 Jul;93(7):2693-701
pubmed: 18445674
Clin Chem Lab Med. 2012 Nov;50(11):2031-2
pubmed: 23096759
Diabetes Obes Metab. 2016 Apr;18(4):392-400
pubmed: 26700109
Anal Biochem. 2011 Nov 1;418(1):126-33
pubmed: 21784054
J Clin Endocrinol Metab. 2011 Mar;96(3):E447-52
pubmed: 21177785
BMC Public Health. 2013 Oct 23;13:999
pubmed: 24152375
Drug Metab Dispos. 2018 Apr;46(4):367-379
pubmed: 29343609
Am J Clin Nutr. 1998 Oct;68(4):854-8
pubmed: 9771862
J Clin Endocrinol Metab. 2008 Mar;93(3):677-81
pubmed: 18089691
J Clin Endocrinol Metab. 2013 Nov;98(11):4339-45
pubmed: 24001747
Am J Clin Nutr. 2012 Jun;95(6):1357-64
pubmed: 22552031
Bone Miner. 1986 Oct;1(5):407-13
pubmed: 2849489
J Clin Endocrinol Metab. 2008 Aug;93(8):3015-20
pubmed: 18492750
Br J Nutr. 2013 Mar 28;109(6):1082-8
pubmed: 23168298
Clin Infect Dis. 2019 Aug 16;69(5):813-819
pubmed: 30481273
J Clin Endocrinol Metab. 2013 Mar;98(3):973-9
pubmed: 23386645
Bone. 2009 Nov;45(5):870-5
pubmed: 19631774

Auteurs

Adrian R Martineau (AR)

Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.

Kenneth E Thummel (KE)

Department of Pharmaceutics, University of Washington, Seattle, Washington.

Zhican Wang (Z)

Department of Pharmaceutics, University of Washington, Seattle, Washington.

David A Jolliffe (DA)

Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.

Barbara J Boucher (BJ)

Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.

Simon J Griffin (SJ)

Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.

Nita G Forouhi (NG)

Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.

Graham A Hitman (GA)

Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH